SIGN UP
LOG IN
X
XTLB
Xtl Biopharmaceu
1.61
0.08+4.96%Opening13:06 05/02 EDT
OPEN/PREV CLOSE1.600/1.530
TODAY RANGE1.560-1.619
VOL2.35K
MARKET CAP14.15M
52 WEEK RANGE0.9208-3.150
AVG VOL (3M)6.71K
% TURNOVER0.03%
TURNOVER--
P/E (TTM)-9.4911
% RANGE3.86%
EPS(TTM)-0.1692
P/E(FORWARD)-6.6600
P/B2.476
BVPS0.6486
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP13.09M
SHARES OUTSTANDING8.81M
NEXT EARNINGS--
FREE FLOAT8.15M
LOT SIZE1
EX-DIV DATE02/10/2017
News
Press Releases
Financial Reports
Profile
TipRanks·04/07 13:20
XTL Biopharmaceuticals appoints Noam Band as CEO
Barchart·04/07 08:15
XTL Names Mr. Noam Band as its New Chief Executive Officer
Benzinga·03/27 12:05
12 Health Care Stocks Moving In Thursday's Pre-Market Session
TipRanks·03/04 11:47
XTL Biopharmaceuticals Enters Sublicense Agreement with Biossil
TipRanks·02/03 21:29
XTL Biopharmaceuticals Adjusts Board Representation Amid Resignations
TipRanks·12/31/2024 01:17
XTL Biopharmaceuticals Expands Portfolio with Social Proxy Acquisition Amidst Regional Challenges
TipRanks·12/31/2024 01:17
XTL Biopharmaceuticals Reports Financial Results Amid Regional Unrest
TipRanks·11/19/2024 22:58
XTL Biopharmaceuticals Adjusts Shares, Eyes Expansion
TipRanks·11/12/2024 15:40
XTL Biopharmaceuticals Resolves Dispute with Social Proxy
Benzinga·11/04/2024 16:40
12 Health Care Stocks Moving In Monday's Intraday Session
TipRanks·10/15/2024 13:27
XTL Biopharmaceuticals Faces Financial Dispute After Acquisition
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.